Karachi, December 3, 2024 – Citi Pharma Limited has announced a landmark partnership with Mersi Farma, a leading pharmaceutical company based in Indonesia, to advance Active Pharmaceutical Ingredient (API) manufacturing and expand the nutraceutical market in Indonesia.
Lahore, September 20, 2024 — In a historic achievement, Citi Pharma Limited has announced its entry into the U.S. market, becoming Pakistan’s first exporter of nutraceutical products to the United States. The announcement, made in a statement on Friday, marks a significant milestone in the country’s pharmaceutical industry.
Karachi, July 2, 2024 – Citi Pharma Limited Pakistan has announced a landmark agreement with Murli Krishna Pharma Private Limited, an Indian company. The partnership, revealed on Tuesday, aims to enhance the pharmaceutical landscape in Pakistan through the supply of high-quality Active Pharmaceutical Ingredients (APIs) and products.
Citi Pharma Limited, a key player in Pakistan’s pharmaceutical sector, has announced a significant joint venture (JV) with Hangzhou Newsea Technology Co. Ltd, aiming to bolster its Active Pharmaceutical Ingredients (API) manufacturing capabilities.
KARACHI: Citi Pharma Limited on Tuesday announced about 100 per cent increase in its net profit for the half year ended December 31, 2021. The net profit of the company was Rs343 million for the half year ended December 31, 2021 as compared with Rs168 million in the same period of the last year. READ […]
KARACHI: Pakistan Stock Exchange (PSX) on Thursday notified the listing of Citi Pharma Limited (CPHL) and trading of company shares will commence on Friday July 09, 2021. The PSX issued following information of all concerned: 1) Trading in the shares of the Company will commence on the Exchange’s Main Board from Friday, July 09, 2021 and shall […]